Final answer:
Based on daily symptoms, nighttime coughing, and FEV1 values, the patient likely has moderate persistent asthma. Treatment includes long-term control medications and fast-acting bronchodilators. Avoiding triggers and regular healthcare monitoring are essential for managing asthma.
Step-by-step explanation:
Treatment and Classification of Asthma
Asthma is a chronic inflammatory disease of the airways that can cause significant morbidity and mortality. The severity of asthma is determined by both the frequency of symptoms and the level of lung function as measured by forced expiratory volume in one second (FEV1). A patient experiencing daily symptoms, nighttime cough twice a week, and an FEV1 between 60-80% would likely be classified as having moderate persistent asthma. Treatment for this type of asthma typically includes both long-term control medications to prevent attacks, such as inhaled corticosteroids, and fast-acting bronchodilators for relief of symptoms when they occur.
Common triggers for asthma exacerbations include environmental factors such as air pollution, allergens, smoke and viruses. Preventing attacks involves avoiding these triggers whenever possible, and effectively managing the condition with prescribed medications. Monitoring and regular review by a healthcare provider are essential to control symptoms and adjust treatment as necessary.
In conclusion, the described symptoms and FEV1 indicate a type of asthma known as moderate persistent asthma, a condition that requires a comprehensive treatment plan and management strategy to control symptoms and prevent attacks.